Elekta (KTA-B.ST) announced today that it launched its Espirit automated treatment planning system.
Stockholm, Sweden-based Elekta designed its latest and most advanced system to offer significantly faster, automated treatment planning for clinicians, with more personalized and patient-friendly treatments and a degree of precision capable of protecting the mind and the person.
The company said in a news release that Espirit offers superior visualization, remote accessibility and collaboration tools for the treatment team within one single platform.
Among the benefits of the platform, the company said, is accuracy of <0.3 mm, flexible workflow options based on single-session, fractionated, adaptive or staged protocols and a seamless integrated system for end-to-end ease of use.
“Esprit will allow clinicians to take radiosurgery to the next level and treat patients with the highest accuracy, protecting their mind and memories and enabling a higher quality of life,” Elekta President and CEO Gustaf Salford said in the release. “Continuing the Leksell Gamma Knife tradition, Elekta yet again redefines what was thought possible in stereotactic radiosurgery.”